Cell Identity, Plasticity and Therapeutic Vulnerabilities in Cancer

Wednesday, January 27, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Epigenetics & Translational Omics Stage
Day 1 - Wednesday 27th January
CancerEpigenetics

Information

  • Understanding how targeted therapies induce cancer cell death and how these effects can be optimised 
  • Exploring how transcription factors such as MYC, p53 and RAS interact with epigenetic context to produce distinct outcomes across different cell types 
  • Investigating the role of cell identity and tumour plasticity in cancer progression and therapeutic response 
  • Understanding how cancer cells lose their normal cellular fate and how targeting MYC may help lock tumour cells into more stable states 
  • Addressing a central question in cancer biology: why the same signalling pathways can drive very different behaviours in different tissues